FeesSafety
Pluang+

Law firm investigates Rafael Holdings over possible securities fraud after failed drug trial data.

Market News
20 Oct 2026, 23:14 WIB
GlobeNewsWire
View Source
Bearish
Law firm investigates Rafael Holdings over possible securities fraud after failed drug trial data.

Pomerantz LLP is investigating Rafael Holdings and its executives for potential securities fraud following the company's announcement that its Phase 3 trial for a Niemann-Pick Disease Type C treatment did not meet statistical significance. This news caused Rafael's stock to drop nearly 35% in one day. The investigation aims to determine if the company misled investors or engaged in unlawful business practices. Investors affected by the stock drop may join a class action lawsuit.

The investigation into Rafael Holdings, Inc. provides context for readers interested in related market activity. For readers following the health sector, here is Pluang's market snapshot as of Oct 21, 2026 03:11 WIB: out of 150 priced health-sector US stocks, 124 rose and 26 fell. Notable movers include RVMD at USD 196.30 with a 7.77% increase, TNGX at USD 25.31 up 7.56%, and AMWL at USD 13.25 rising 7.46%.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App